Rx Name [VALACYCLOVIR, 081832]
|
|
PMS-VALACYCLOVIR 500MG CAP (PMS/COL)
|
|
|
|
|
|
081832
|
|
|
NUCLEOSIDES AND NUCLEOTIDES
|
|
|
.Effective in treating initial or recurrent herpes simplex virus, herpes zoster and varicella zoster virus infections
|
|
|
Valacyclovir is generally well tolerated. GI disturbances, nausea, abdominal pain, renal failure, local reactions at the injection site, headache and rash may occur.
A finger cot or rubber glove should be utilized for application to prevent auto-innoculation of other body sites |
|
|
Herpes zoster: 1g 3 times daily for 7 day s; Herp es simp lex: 500 mg twice daily for 3 to 5 day s for recurrent ep isodes or for up to 10 day s for a first ep isode. Treatment should be started as soon as sy mp toms occur; ideally within 48 to 72 hours.
|
|
|
|
|
|
Not known to be harmful—manufacturers advise use only when potential benefit outweighs risk.
|
|
|
Significant amount in milk after systemic administration—not known to be harmful but manufacturer advises caution.
|
|
|
|